Article Details
Retrieved on: 2021-08-16 15:24:43
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
On August 10, Finch Therapeutics announced that FIN-524, its microbiome-targeting drug candidate for the treatment of ulcerative colitis (UC), will be ...
Article found on: www.clinicaltrialsarena.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here